Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 4/20 | 0.38 |
| ▸ | ACHE | P22303 | 4/20 | 0.38 |
| ▸ | F10 | P00742 | 1/20 | 0.36 |
| ▸ | SYK | P43405 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | DUT | P33316 | 1/20 | 0.34 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.32 |
| ▸ | IDH1 | O75874 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15744663 | 0.91 | SYK (0.36) | BCHEACHESYKMAPK1ADRB3 | |
| SCHEMBL15744891 | 0.87 | MAPK1 (0.36) | BCHEACHEF10SYKMAPK1 | |
| SCHEMBL15744664 | 0.81 | ADRB3 (0.39) | MAPK1ADRB3 | |
| SCHEMBL15744665 | 0.71 | ALDH1A1 (0.41) | BCHEACHEMAPK1ADRB3GAA | |
| SCHEMBL3050926 | 0.70 | MAPK1 (0.49) | SYKMAPK1ALDH1A1 | |
| SCHEMBL15744661 | 0.70 | PTPN1 (0.48) | PTPN1GAAALDH1A1 | |
| SCHEMBL15745135 | 0.70 | ALDH1A1 (0.49) | MAPK1ALDH1A1 | |
| SCHEMBL1025346 | 0.70 | CA12 (0.45) | ALDH1A1NLRP3 | |
| SCHEMBL13508358 | 0.70 | ESR1 (0.43) | MAPK1ESR1ALDH1A1NLRP3 | |
| SCHEMBL3686106 | 0.70 | ESR1 (0.43) | MAPK1ESR1ALDH1A1NLRP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9360474-B2 | Multi-layer device for selectively determining magnesium ion | OPTI MEDICAL SYSTEMS, INC. (US) | 2016-06-07 | — | — | US | disclosed |
| US-20140147876-A1 | MULTI-LAYER DEVICE FOR SELECTIVELY DETERMINING MAGNESIUM ION | IDEXX LABORATORIES, INC. (US) | 2014-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140147876-A1 | MULTI-LAYER DEVICE FOR SELECTIVELY DETERMINING MAGNESIUM ION | ORAI1, CACYBP, CASR | BCHE 3866/4885ACHE 657/4885F10 1536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.